How does 68 Ga‐prostate‐specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How does
68
Ga‐prostate‐specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF UROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-14
DOI
10.1111/iju.14012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA
- (2018) Andrea Farolfi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
- (2018) Paola Caroli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy
- (2018) Isabel Rauscher et al. EUROPEAN UROLOGY
- Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- (2018) Sangwon Han et al. EUROPEAN UROLOGY
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
- (2017) B. Grubmüller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
- (2017) Stefano Fanti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Salvage Surgery for Nodal Recurrence of Prostate Cancer: Might the Robotic Approach Render an Experimental Procedure More Acceptable?
- (2017) Riccardo Schiavina et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Impact of68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
- (2017) Asim Afaq et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
- (2017) Jeremie Calais et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
- (2017) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
- (2016) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Marlon Perera et al. EUROPEAN UROLOGY
- Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy
- (2016) I. Rauscher et al. JOURNAL OF NUCLEAR MEDICINE
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
- (2016) Peter R. Carroll et al. Journal of the National Comprehensive Cancer Network
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
- (2016) Isabel Rauscher et al. CANCER IMAGING
- 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2015) Piet Ost et al. EUROPEAN UROLOGY
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study
- (2015) Axel Heidenreich et al. JOURNAL OF UROLOGY
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
- (2014) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group
- (2008) Mark A. Sidhom et al. RADIOTHERAPY AND ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started